Researchers used visual flickering sensory stimulation to reveal the underlying mechanisms governing microglial morphology and cytokine expression in mice.
FDA+ roundup: Agency reopens AI discussion paper for comments amid two-day workshop
The FDA is reopening the comment period on its discussion paper on using artificial intelligence in drug development, coinciding with a two-day workshop on the
September 28, 2023